Versican Plus BbPi IN
Active substance
ATC code
Species
Dogs
Indications
Active immunisation of dogs from 3 weeks of age:
- to reduce clinical signs and bacterial excretion after infection with Bordetella bronchiseptica and
- to reduce clinical signs and viral excretion after infection with canine parainfluenza virus.
| Onset of immunity: | 3 days after primary vaccination for Bordetella bronchiseptica. |
| 7 days after primary vaccination for canine parainfluenza virus. |
Duration of immunity: 1 year.
Dose to be administered and administration route
Nasal use.
Dosage and route of administration:
Aseptically reconstitute the lyophilisate with the solvent. Shake well after reconstitution. Withdraw the liquid with the syringe, remove the needle and administer directly from the tip of the syringe into one nostril. Alternatively, an intranasal applicator (available separately) can be attached to the syringe and the dose then administered into one nostril. The veterinary medicinal product should then be used immediately.
The head of the dog should be held with the nose pointing upwards. Administer one dose (0.5 ml) of the reconstituted veterinary medicinal product into one nostril.
Appearance of the reconstituted vaccine: whitish to yellowish colour with light opalescence.
Primary vaccination scheme:
A single dose from 3 weeks of age.
Re-vaccination scheme:
A single dose to be given annually.
Adverse reactions
Dogs:
|
Very common (>1 animal / 10 animals treated): |
Nasal discharge1 |
|
Common (1 to 10 animals / 100 animals treated): |
Ocular discharge1 Cough2 Depression1 |
|
Uncommon (1 to 10 animals / 1,000 animals treated): |
Sneezing1 |
1Mild and generally subside without treatment within 1 to 3 days.
2Mild to moderate and observed in vaccinated dogs within 48 hours to one week after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.
